BNP Paribas Financial Markets
PMD

BNP Paribas Financial Markets’s Psychemedics Corporation PMD Stock Holding History

BNP Paribas Financial Markets’s Portfolio PMD Stock Details PMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-12
Closed -$170 – 4309
2014
Q2 		$170 Hold
12
– – ﹤0.01% 3723
2014
Q1 		$189 Hold
12
– – ﹤0.01% 3222
2013
Q4 		$176 Buy
+12
New +$165 ﹤0.01% 4028

Other funds holding PMD

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
KFA
Kelleher Financial Advisors New York $705M AUM 16.14% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
NSIM
North Star Investment Management Chicago, Illinois $1.84B AUM 28.81% 1-Year Est. Return
CIC
Crawford Investment Counsel Atlanta, Georgia $5.85B AUM 12.61% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

BNP Paribas Financial Markets's PMD Position: Q3 2014 in Review

BNP Paribas Financial Markets sold out of Psychemedics Corporation (PMD) in Q3 2014, closing a stake of 12 shares — an estimated $170 sold.

BNP Paribas Financial Markets first reported a position in PMD in Q4 2013 and held it in 3 quarters. The position peaked at $189 in Q1 2014. 33 funds tracked by Wall St. Rank hold PMD as of Q3 2014.

  • BNP Paribas Financial Markets reported no remaining Psychemedics Corporation position as of Q3 2014 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 12 Psychemedics Corporation shares in Q3 2014, an estimated $170.
  • BNP Paribas Financial Markets first reported a position in Psychemedics Corporation in Q4 2013 and held it in 3 quarters.
  • BNP Paribas Financial Markets's Psychemedics Corporation position peaked at $189 in Q1 2014.
  • 33 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q3 2014.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2014, filed 12 Nov 2014.